Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life

P B Jeppesen, P Lund, I B Gottschalck, H B Nielsen, Jens Juul Holst, J Mortensen, S S Poulsen, Bjørn Quistorff, P B Mortensen

Fingerprint

Dive into the research topics of 'Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life'. Together they form a unique fingerprint.

Medicine & Life Sciences